Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Angiology|June 24, 2016
Associations Between Cardio-Ankle Vascular Index and Aortic Structure and Sclerosis Using Multidetector Computed TomographyShigeo Horinaka, Hiroshi Yagi, Hiromichi Fukushima, et al.
International Journal of Molecular Sciences|December 24, 2021
Decreased Podocyte Vesicle Transcytosis and Albuminuria in APC C-Terminal Deficiency Mice with Puromycin-Induced Nephrotic SyndromeSaaya Hatakeyama, Akihiro Tojo, Hiroshi Satonaka, et al.
Medicine|November 7, 2019
Rituximab in treatment of anti-GBM antibody glomerulonephritis: A case report and literature reviewMayu Uematsu-Uchida, Takehiro Ohira, Shigeki Tomita, et al.
Angiology|March 23, 2011
Cardio-ankle vascular index could reflect plaque burden in the coronary arteryShigeo Horinaka, Akihisa Yabe, Hiroshi Yagi, et al.
American Journal of Hypertension|February 28, 2002
Effects of alcohol restriction on ambulatory blood pressure, heart rate, and heart rate variability in Japanese menJunichi Minami, Masayoshi Yoshii, Masakatsu Todoroki, et al.
Clinical Science (London, England : 1979)|August 1, 2002
Effects of smoking cessation or alcohol restriction on metabolic and fibrinolytic variables in Japanese menJunichi Minami, Masakatsu Todoroki, Masayoshi Yoshii, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2004
Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphismToshihiko Ishimitsu, Kohju Tsukada, Satoshi Ohta, et al.
Atherosclerosis|May 28, 2014
Cardio-ankle vascular index (CAVI) correlates with aortic stiffness in the thoracic aorta using ECG-gated multi-detector row computed tomographyShigeo Horinaka, Hiroshi Yagi, Kimihiko Ishimura, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 16, 2015
The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) studyToshihiko Ishimitsu, Hirofumi Fukuda, Masako Uchida, et al.
British Journal of Clinical Pharmacology|April 20, 2004
Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertensionJunichi Minami, Atsushi Numabe, Norikazu Andoh, et al.
Pageof 10